• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Unraveling the realities of vascular access: the Network 11 experience.

作者信息

Besarab A, Adams M, Amatucci S, Bowe D, Deane J, Ketchen K, Reynolds K, Tello A

机构信息

Renal Network of the Upper Midwest, Inc, ESRD Network 11, St. Paul, MN 55114, USA.

出版信息

Adv Ren Replace Ther. 2000 Oct;7(4 Suppl 1):S65-70.

PMID:11053589
Abstract

Arteriovenous (AV) fistulae are well recognized as the preferred vascular access for hemodialysis, yet national data show that only 23% of patients used an AV fistula in 1997. To identify barriers to the placement of native AV fistulae, the Renal Network of the Upper Midwest, Inc. (End-Stage Renal Disease [ESRD] Network 11) initiated a vascular access project to look at the process of referral for patients beginning hemodialysis in the first 6 months of 1999. Of these patients, 63% began hemodialysis with a catheter as the only access, 22% had an AV fistula placed (but only 14% used an AV fistula for their first dialysis treatment), and 15% began with a graft. About 40% of patients were referred to a nephrologist less than 1 month before dialysis, allowing little chance for permanent access placement. Yet 27% of patients used a catheter on the first hemodialysis treatment and were seen by a nephrologist more than 1 month before starting dialysis, indicating the presence of an opportunity to improve. At 6 months after initiation of dialysis, 25% of patients who began dialysis using a catheter were using an AV fistula and 35% were using a graft. Network 11 plans to use this information to promote early referral of patients to a nephrologist and subsequent prompt referral of such patients to a vascular surgeon. Other activities to improve vascular access management are also indicated.

摘要

相似文献

1
Unraveling the realities of vascular access: the Network 11 experience.
Adv Ren Replace Ther. 2000 Oct;7(4 Suppl 1):S65-70.
2
First hemodialysis access selection varies with patient acuity.首次血液透析通路的选择因患者的急症情况而异。
Adv Ren Replace Ther. 2000 Oct;7(4 Suppl 1):S4-10.
3
Timing of nephrologist referral and arteriovenous access use: the CHOICE Study.肾病科医生转诊时机与动静脉通路使用情况:CHOICE研究
Am J Kidney Dis. 2001 Sep;38(3):494-501. doi: 10.1053/ajkd.2001.26833.
4
Managing the lifeline: preemptive access management for better outcomes for hemodialysis patients and programs. Medical Review Board of The Renal Network, Inc.管理生命线:为血液透析患者和项目实现更好结果的抢先访问管理。肾脏网络公司医学审查委员会
Adv Ren Replace Ther. 2000 Oct;7(4 Suppl 1):S45-55.
5
Increasing the use of arteriovenous fistula in hemodialysis: economic benefits and economic barriers.增加动静脉内瘘在血液透析中的使用:经济效益与经济障碍。
Clin J Am Soc Nephrol. 2007 Mar;2(2):268-76. doi: 10.2215/CJN.01880606. Epub 2007 Jan 24.
6
[Analysis of the survival of permanent vascular access ports].[永久性血管通路端口的存活情况分析]
Nefrologia. 2001 May-Jun;21(3):260-73.
7
[Fistulae or catheter for elderly who start hemodialysis without permanent vascular access?].[对于开始血液透析但没有永久性血管通路的老年人,应选择瘘管还是导管?]
Nefrologia. 2005;25(3):307-14.
8
Conversion of vascular access type among incident hemodialysis patients: description and association with mortality.新接受血液透析患者的血管通路类型转换:描述及其与死亡率的关联
Am J Kidney Dis. 2009 May;53(5):804-14. doi: 10.1053/j.ajkd.2008.11.031. Epub 2009 Mar 5.
9
Catheter use remains center of debate in success of Fistula First.在“动静脉内瘘优先”策略的成功实施中,导管的使用仍是争论的焦点。
Nephrol News Issues. 2008 May;22(6):38, 40.
10
How a dedicated vascular access center can promote increased use of fistulas.一个专门的血管通路中心如何促进动静脉内瘘使用的增加。
Nephrol Nurs J. 2006 Mar-Apr;33(2):189-96.

引用本文的文献

1
Prophylaxis of catheter-related bacteremia using tissue plasminogen activator-tobramycin locks.使用组织型纤溶酶原激活剂-妥布霉素封管预防导管相关菌血症
Pediatr Nephrol. 2009 Nov;24(11):2233-43. doi: 10.1007/s00467-009-1235-5. Epub 2009 Jul 10.
2
Comparison of early versus late use of antibiotic locks in the treatment of catheter-related bacteremia.抗生素封管液早期与晚期应用治疗导管相关菌血症的比较。
Clin J Am Soc Nephrol. 2008 Jul;3(4):1048-56. doi: 10.2215/CJN.04931107. Epub 2008 Apr 9.
3
Treatment of catheter-related bacteremia with tissue plasminogen activator antibiotic locks.
用组织型纤溶酶原激活剂抗生素封管治疗导管相关菌血症
Pediatr Nephrol. 2008 Mar;23(3):457-64. doi: 10.1007/s00467-007-0687-8. Epub 2007 Dec 6.
4
Central venous catheters as a vascular access modality for pediatric hemodialysis.中心静脉导管作为儿科血液透析的血管通路方式。
Int Urol Nephrol. 2008;40(2):489-96. doi: 10.1007/s11255-007-9259-x.
5
Advancing age and the risk of nasal carriage of Staphylococcus aureus among patients on long-term hospital-based hemodialysis.长期住院血液透析患者的年龄增长与金黄色葡萄球菌鼻腔携带风险
Ann Saudi Med. 2004 Sep-Oct;24(5):337-42. doi: 10.5144/0256-4947.2004.337.